- Home
- FENC vs FCT Comparison
FENC vs FCT Comparison
Compare FENC & FCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- FCT
- Stock Information
- Founded
- FENC 1996
- FCT 2004
- Country
- FENC United States
- FCT United States
- Employees
- FENC N/A
- FCT N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- FCT Finance Companies
- Sector
- FENC Health Care
- FCT Finance
- Exchange
- FENC Nasdaq
- FCT Nasdaq
- Market Cap
- FENC 222.9M
- FCT 255.2M
- IPO Year
- FENC 2001
- FCT N/A
- Fundamental
- Price
- FENC $8.63
- FCT $10.21
- Analyst Decision
- FENC Strong Buy
- FCT
- Analyst Count
- FENC 2
- FCT 0
- Target Price
- FENC $13.00
- FCT N/A
- AVG Volume (30 Days)
- FENC 68.5K
- FCT 106.8K
- Earning Date
- FENC 08-12-2025
- FCT 01-01-0001
- Dividend Yield
- FENC N/A
- FCT 11.29%
- EPS Growth
- FENC N/A
- FCT N/A
- EPS
- FENC N/A
- FCT N/A
- Revenue
- FENC $30,912,000.00
- FCT N/A
- Revenue This Year
- FENC $0.85
- FCT N/A
- Revenue Next Year
- FENC $55.16
- FCT N/A
- P/E Ratio
- FENC N/A
- FCT N/A
- Revenue Growth
- FENC N/A
- FCT N/A
- 52 Week Low
- FENC $3.96
- FCT $9.45
- 52 Week High
- FENC $9.30
- FCT $10.42
- Technical
- Relative Strength Index (RSI)
- FENC 53.93
- FCT 64.85
- Support Level
- FENC $8.28
- FCT $10.16
- Resistance Level
- FENC $8.94
- FCT $10.22
- Average True Range (ATR)
- FENC 0.36
- FCT 0.06
- MACD
- FENC -0.05
- FCT 0.00
- Stochastic Oscillator
- FENC 34.31
- FCT 81.82
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest
First Trust Senior Floating Rate Income Fund II is the United States based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, the fund attempts to preserve capital. The fund seeks to achieve the objectives by investing in a portfolio of senior floating-rate loan interests. Its portfolio of investments consists of aerospace and defense, agricultural products, broadcasting, cable and satellite, electric utilities and other sectors.